with a safety and tolerability profile comparable to semaglutide 2.4 mg,” said Martin Holst Lange, executive vice president for Development at Novo Nordisk. “Results from STEP UP further ...

The company states: “Novo Nordisk (NVO) announced headline results ... and safety trial investigating subcutaneous semaglutide 7.2 mg compared to semaglutide 2.4 mg and placebo, all administered ...

Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...

Novo Nordisk's GLP-1 weight loss drugs, Ozempic and Wegovy, will be targeted in the next round of Medicare price negotiations in 2027, along with 13 other medications.Seana Smith and Brad Smith ...

Nintendo has unveiled the long-awaited successor to its popular Switch video game console: the Nintendo Switch 2. First-look images at the console design and a teaser trailer were revealed by ...

Nintendo finally unveils the Switch 2 console confirming features like magnetic Joy-Cons and an optical sensor. The official trailer also confirms backward compatibility with Switch games and ...

HONOLULU (KHON2) — The Maui County Fair was a beloved community event with a rich history dating back to 1916. But like so many things, it became a casualty of the pandemic. Now after a four ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As the many leaks and rumors suggested, Nintendo Switch 2 is the name of the company’s new hardware, and while it shares plenty in common with its predecessor, there are some big design upgrades ...

Nintendo has finally revealed the Switch 2 console in a trailer showing off the handheld. Of course, many fans already knew details about the console due to leaks leading up to the reveal ...

while Wegovy rocketed 79% to $2.5 billion. The breakneck pace of growth with the two drugs has helped to catapult Novo Nordisk's valuation to $289 billion, making it one of Europe's most valuable ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...